ROCKET PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ROCKET PHARMACEUTICALS, INC. has filed 939 SEC EDGAR filings since 25 Feb 2004

SEC filing history

Showing 276-300 of 936 matching filings.

Per page
25
Current page
12
4

FORM 4

Filing date
24 Apr 2024
Reporting date
22 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
22 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36829

PRE 14A

Filing date
17 Apr 2024
Reporting date
13 Jun 2024
Next action
Verify source filing
4

FORM 4

Filing date
16 Apr 2024
Reporting date
12 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
15 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
12 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
08 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88750

SEC SCHEDULE 13G

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Apr 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
03 Apr 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Mar 2024
Reporting date
21 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Mar 2024
Reporting date
21 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2024
Reporting date
29 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Mar 2024
Reporting date
29 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
29 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36829

144 filing

Filing date
29 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Feb 2024
Reporting date
16 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Feb 2024
Reporting date
16 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Feb 2024
Reporting date
16 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .